From: The Th17/Treg balance and the expression of related cytokines in Uygur cervical cancer patients
Percentages (%) of cells | UCC group | CIN group | Control group |
---|---|---|---|
CD4+CD25+Treg | 13.31 ± 2.02 | 12.75 ± 2.61 | 6.99 ± 1.62 |
CD4+CD25+ CD127-Treg | 6.43 ± 1.04a | 6.13 ± 1.23a | 3.78 ± 0.70 |
CD8+CD25+CD127-Treg | 3.01 ± 1.21 | 2.66 ± 1.45 | 1.73 ± 1.03 |
CD4+CD25+Foxp3+ | 6.81 ± 1.03 | 6.35 ± 1.75 | 2.81 ± 1.41 |
CD4+CD25-Foxp3+ | 3.52 ± 1.45 | 3.15 ± 1.38 | 1.53 ± 0.87 |
CD8+CD25+Foxp3+ Treg | 0.81 ± 0.19 | 0.74 ± 0.23 | 0.27 ± 0.16 |
CD4+IL17+Th17 | 3.54 ± 1.44 | 3.29 ± 1.45 | 0.96 ± 0.54 |